- Assessing a policy roadmap towards an EU and Global Action Plan for Rare Diseases (GAPRD)
- How will the WHO UN Resolution impact rare diseases in 2026 and what progress has been made?
- How can regions come together to harmonise, collaborate and put patients’ needs at the forefront of decision making?
Case study example of multi-year, multi-indication (MYMI) agreements in Belgium, Italy, Netherlands and UK
- Assessing a policy roadmap towards an EU and Global Action Plan for Rare Diseases (GAPRD)
- How will the WHO UN Resolution impact rare diseases in 2026 and what progress has been made?
- How can regions come together to harmonise, collaborate and put patients’ needs at the forefront of decision making?